699O Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers

Thomas Powles, Yohann Loriot, Joaquim Bellmunt, Cora N. Sternberg, Srikala S. Sridhar, Daniel P. Petrylak, Rosa Tambaro, Louis-Marie Dourthe, Carlos Álvarez-Fernández, M. Aarts, Xinmeng Jasmine Mu, Keith A. Ching, Jie Pu, Satrajit Roychoudhury, Craig B. Davis, Alessandra di Pietro, Petros Grivas